Fake pills keep circulating, despite law coming into effect; faulty oxygen readings delayed Covid care for darker-skinned patients

Gilead and Johnson & Johnson have been hit by a sweeping and sophisticated counterfeit drug scheme involving HIV medicines. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      STAT+: While a law designed to thwart counterfeit medicines lurches into full force, fake pills keep circulating By Ed Silverman and Jonathan Wosen Alex Hogan/STAT, Adobe Gilead and Johnson & Johnson have been hit by a sweeping and sophisticated counterfeit drug scheme involving HIV medicines. Read More Faulty oxygen readings delayed Covid treatments for darker-skinned patients, study finds By Usha Lee McFarling Spencer Platt/Getty Images Undetected low oxygen levels led to delays in Black and Hispanic patients receiving therapies such as the drugs remdesivir and dexamethasone. Read More STAT+: The American Medical Association is fighting an otherwise popular bill to require training doctors about opioid use disorder By Nicholas Florko Adobe The American Medical Association is fighting an otherwise popular bill that would require training doctors about opioid use disorder. Read More Sponsor content by Exact Sciences Accelerating the cancer moonshot through collaboration Today's moonshot is undoubtedly cancer, and the time to act is now. Eradicating cancer or, at the very least, turning it into a much more manageable disease — is an audacious goal. Yet, if we invest today, it is something our children and grandchildren will live to see. Learn more about cancer innovations and options in earlier detection. STAT+: Documents show problems at Novartis facility where cancer drug production was halted By Ed Silverman FABRICE COFFRINI/AFP/Getty Images Documents reviewed by STAT illustrate issues at a Novartis facility where production of a cancer treatment was halted this month. Read More Mistreatment in medical school leads students to leave, with students of color faring the worst By Usha Lee McFarling Darren Hauck/Getty Images Medical students who report being mistreated or discriminated against are far more likely to drop out of medical school, a new study finds. Read More Opinion: Factoring in patients' experiences is essential for moving the needle on health disparities By Sylvie Leotin Adobe To uproot health inequities in the U.S. for centuries, it is essential to understand the experiences of underserved and marginalized people. Read More STAT+: Former AstraZeneca executive accused of insider trading over Daiichi cancer drug deal By Ed Silverman BRYAN R. SMITH/AFP via Getty Images A former AstraZeneca communications executive was accused of insider trading in connection with a partnership with Daiichi Sankyo. Read More Tuesday, May 31, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser